People · Operator
Named in public records as an officer, director or promoter · active 2008–2016 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Numira Biosciences Inc | — | Biotechnology | Seed | $3.3M | $145.8M | 2009 |
| Gliamed Inc | — | Biotechnology | Seed | $2.5M | $109.5M | 2008 |
| RiverTown Therapeutics, Inc. | — | Biotechnology | Pre-Seed | $133K | $7.3M | 2016 |
David Weinstein at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Weinstein on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Dinesh Patel | 1 | 13 |
| Paul Grint | 1 | 5 |
| Michael Altman | 1 | 3 |
| Andrew Busser | 1 | 2 |
| Barry Dickman | 1 | 2 |
| Michael Beeuwsaert | 1 | 1 |
| Anthony Purchio | 1 | 1 |
| Paul DeRidder | 1 | 1 |
| Andrew Uprichard | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.